WORCESTER, Mass., June 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that all of the 8% Senior Secured Convertible Notes issued by the Company on March 31, 2008 have been satisfied in full and no longer are outstanding.
